Published in J Int Neuropsychol Soc on December 11, 2009
CSF biomarkers cutoffs: the importance of coincident neuropathological diseases. Acta Neuropathol (2012) 1.70
Cognition and neuropsychiatry in behavioral variant frontotemporal dementia by disease stage. Neurology (2016) 0.80
Differential longitudinal decline on the Mini-Mental State Examination in frontotemporal lobar degeneration and Alzheimer disease. Alzheimer Dis Assoc Disord (2013) 0.79
Effects of Delay Duration on the WMS Logical Memory Performance of Older Adults with Probable Alzheimer's Disease, Probable Vascular Dementia, and Normal Cognition. Arch Clin Neuropsychol (2017) 0.75
Multimodal comparative studies of neurodegenerative diseases. J Alzheimers Dis (2013) 0.75
Effects of Delay Duration on the WMS Logical Memory Performance of Older Adults with Probable Alzheimer's Disease, Probable Vascular Dementia, and Normal Cognition. Arch Clin Neuropsychol (2017) 0.75
Transcranial direct current stimulation for the treatment of primary progressive aphasia: An open-label pilot study. Brain Lang (2016) 0.75
"Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res (1975) 301.74
Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology (1984) 119.59
Random-effects models for longitudinal data. Biometrics (1982) 54.17
Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology (1998) 26.77
The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease. Neurology (1989) 16.83
Clinical and pathological diagnosis of frontotemporal dementia: report of the Work Group on Frontotemporal Dementia and Pick's Disease. Arch Neurol (2001) 9.96
Role of left inferior prefrontal cortex in retrieval of semantic knowledge: a reevaluation. Proc Natl Acad Sci U S A (1997) 7.19
The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer's disease. Cereb Cortex (1992) 5.57
Clinical and neuropathological criteria for frontotemporal dementia. The Lund and Manchester Groups. J Neurol Neurosurg Psychiatry (1994) 5.40
Frontotemporal dementia: clinicopathological correlations. Ann Neurol (2006) 5.14
The parietal cortex and episodic memory: an attentional account. Nat Rev Neurosci (2008) 4.30
Distinctive neuropsychological patterns in frontotemporal dementia, semantic dementia, and Alzheimer disease. Cogn Behav Neurol (2003) 3.66
The evolution and pathology of frontotemporal dementia. Brain (2005) 3.46
Functional neuroanatomy of remote episodic, semantic and spatial memory: a unified account based on multiple trace theory. J Anat (2005) 3.14
Frontal behavioral inventory: diagnostic criteria for frontal lobe dementia. Can J Neurol Sci (1997) 2.23
Cognitive and motor assessment in autopsy-proven corticobasal degeneration. Neurology (2007) 2.09
Primary progressive aphasia: a review. Neurocase (2004) 2.08
The corticobasal degeneration syndrome overlaps progressive aphasia and frontotemporal dementia. Neurology (2000) 2.04
Prefrontal cortex and episodic memory retrieval mode. Proc Natl Acad Sci U S A (2000) 1.80
Distinct antemortem profiles in patients with pathologically defined frontotemporal dementia. Arch Neurol (2007) 1.60
Cognitive profiles differ in autopsy-confirmed frontotemporal dementia and AD. Neurology (2002) 1.49
Longitudinal decline in autopsy-defined frontotemporal lobar degeneration. Neurology (2008) 1.48
Disparate letter and semantic category fluency deficits in autopsy-confirmed frontotemporal dementia and Alzheimer's disease. Neuropsychology (2007) 1.37
Neuropsychological decline in frontotemporal lobar degeneration: a longitudinal analysis. Neuropsychology (2009) 1.35
A longitudinal study of language decline in Alzheimer's disease and frontotemporal dementia. J Int Neuropsychol Soc (2007) 1.28
Screening for frontotemporal dementias and Alzheimer's disease with the Philadelphia Brief Assessment of Cognition: a preliminary analysis. Dement Geriatr Cogn Disord (2007) 1.26
Language comprehension profiles in Alzheimer's disease, multi-infarct dementia, and frontotemporal degeneration. Neurology (1996) 1.13
A longitudinal study of behavior in frontotemporal dementia and primary progressive aphasia. Cogn Behav Neurol (2004) 1.11
Clinical and pathological overlap between frontotemporal dementia, primary progressive aphasia and corticobasal degeneration: the Pick complex. Dement Geriatr Cogn Disord (1999) 1.10
Constraints on the cerebral basis for semantic processing from neuroimaging studies of Alzheimer's disease. J Neurol Neurosurg Psychiatry (1997) 1.07
Episodic memory and regional atrophy in frontotemporal lobar degeneration. Neuropsychologia (2007) 0.89
Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science (2006) 27.96
Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain (2011) 9.90
Risk of myocardial infarction in patients with psoriasis. JAMA (2006) 9.42
Validation studies of the health improvement network (THIN) database for pharmacoepidemiology research. Pharmacoepidemiol Drug Saf (2007) 5.93
Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions. Nat Genet (2010) 5.52
TARDBP mutations in amyotrophic lateral sclerosis with TDP-43 neuropathology: a genetic and histopathological analysis. Lancet Neurol (2008) 5.33
Frontotemporal dementia: clinicopathological correlations. Ann Neurol (2006) 5.14
Pathological heterogeneity of frontotemporal lobar degeneration with ubiquitin-positive inclusions delineated by ubiquitin immunohistochemistry and novel monoclonal antibodies. Am J Pathol (2006) 4.32
Prevalence of cardiovascular risk factors in patients with psoriasis. J Am Acad Dermatol (2006) 4.12
Mutations in GNAL cause primary torsion dystonia. Nat Genet (2012) 3.66
Plasma multianalyte profiling in mild cognitive impairment and Alzheimer disease. Neurology (2012) 3.58
Co-morbidity of TDP-43 proteinopathy in Lewy body related diseases. Acta Neuropathol (2007) 3.55
Biochemical and pathological characterization of Lrrk2. Ann Neurol (2006) 3.14
Cerebrospinal fluid profile in frontotemporal dementia and Alzheimer's disease. Ann Neurol (2005) 3.09
Criteria for the diagnosis of corticobasal degeneration. Neurology (2013) 3.07
The risk of stroke in patients with psoriasis. J Invest Dermatol (2009) 2.97
Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy. Nat Genet (2011) 2.97
Concomitant TAR-DNA-binding protein 43 pathology is present in Alzheimer disease and corticobasal degeneration but not in other tauopathies. J Neuropathol Exp Neurol (2008) 2.96
What's in a name: voxel-based morphometric analyses of MRI and naming difficulty in Alzheimer's disease, frontotemporal dementia and corticobasal degeneration. Brain (2004) 2.90
Clinical and pathological continuum of multisystem TDP-43 proteinopathies. Arch Neurol (2009) 2.68
Working memory for conjunctions relies on the medial temporal lobe. J Neurosci (2006) 2.59
Diagnostic criteria for the behavioral variant of frontotemporal dementia (bvFTD): current limitations and future directions. Alzheimer Dis Assoc Disord (2007) 2.43
Enrichment of C-terminal fragments in TAR DNA-binding protein-43 cytoplasmic inclusions in brain but not in spinal cord of frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Am J Pathol (2008) 2.41
Deep brain stimulation in the treatment of obesity. J Neurosurg (2008) 2.40
A multicenter study of glucocerebrosidase mutations in dementia with Lewy bodies. JAMA Neurol (2013) 2.32
The risk of mortality in patients with psoriasis: results from a population-based study. Arch Dermatol (2007) 2.32
A high-resolution computational atlas of the human hippocampus from postmortem magnetic resonance imaging at 9.4 T. Neuroimage (2008) 2.25
Plasma epidermal growth factor levels predict cognitive decline in Parkinson disease. Ann Neurol (2010) 2.20
The spectrum of mutations in progranulin: a collaborative study screening 545 cases of neurodegeneration. Arch Neurol (2010) 2.19
Novel CSF biomarkers for Alzheimer's disease and mild cognitive impairment. Acta Neuropathol (2010) 2.12
Neuropathologic substrates of Parkinson disease dementia. Ann Neurol (2012) 2.10
Anterior temporal involvement in semantic word retrieval: voxel-based lesion-symptom mapping evidence from aphasia. Brain (2009) 2.10
Visual working memory is impaired when the medial temporal lobe is damaged. J Cogn Neurosci (2006) 2.06
A placebo-controlled trial of constraint-induced movement therapy for upper extremity after stroke. Stroke (2006) 2.03
TDP-43-positive white matter pathology in frontotemporal lobar degeneration with ubiquitin-positive inclusions. J Neuropathol Exp Neurol (2007) 2.02
Pattern of ubiquilin pathology in ALS and FTLD indicates presence of C9ORF72 hexanucleotide expansion. Acta Neuropathol (2012) 2.01
A double-blind randomized placebo-controlled pilot study of neuropsychiatric adverse events in abstinent smokers treated with varenicline or placebo. Biol Psychiatry (2011) 2.01
Framing Financial Incentives to Increase Physical Activity Among Overweight and Obese Adults: A Randomized, Controlled Trial. Ann Intern Med (2016) 1.96
Montreal cognitive assessment performance in patients with Parkinson's disease with "normal" global cognition according to mini-mental state examination score. J Am Geriatr Soc (2008) 1.92
Localizing interference during naming: convergent neuroimaging and neuropsychological evidence for the function of Broca's area. Proc Natl Acad Sci U S A (2008) 1.89
Validation of the questionnaire for impulsive-compulsive disorders in Parkinson's disease. Mov Disord (2009) 1.89
Memantine in patients with frontotemporal lobar degeneration: a multicentre, randomised, double-blind, placebo-controlled trial. Lancet Neurol (2013) 1.84
Language and the aging brain: patterns of neural compensation revealed by functional brain imaging. J Neurophysiol (2006) 1.82
Hearing loss in older adults affects neural systems supporting speech comprehension. J Neurosci (2011) 1.81
Neural basis for generalized quantifier comprehension. Neuropsychologia (2005) 1.79
Power in Voxel-based lesion-symptom mapping. J Cogn Neurosci (2007) 1.78
White matter imaging helps dissociate tau from TDP-43 in frontotemporal lobar degeneration. J Neurol Neurosurg Psychiatry (2013) 1.74
Registration based cortical thickness measurement. Neuroimage (2008) 1.73
CSF biomarkers cutoffs: the importance of coincident neuropathological diseases. Acta Neuropathol (2012) 1.70
Variations in the progranulin gene affect global gene expression in frontotemporal lobar degeneration. Hum Mol Genet (2008) 1.68
Contribution of cerebrovascular disease in autopsy confirmed neurodegenerative disease cases in the National Alzheimer's Coordinating Centre. Brain (2013) 1.64
The risk of lymphoma in patients with psoriasis. J Invest Dermatol (2006) 1.62
Distinct antemortem profiles in patients with pathologically defined frontotemporal dementia. Arch Neurol (2007) 1.60
TMEM106B, the risk gene for frontotemporal dementia, is regulated by the microRNA-132/212 cluster and affects progranulin pathways. J Neurosci (2012) 1.60
TDP-43 pathologic lesions and clinical phenotype in frontotemporal lobar degeneration with ubiquitin-positive inclusions. Arch Neurol (2007) 1.57
Everyday action in dementia: evidence for differential deficits in Alzheimer's disease versus subcortical vascular dementia. J Int Neuropsychol Soc (2006) 1.56
Effects of nicotine nasal spray on cognitive function in schizophrenia. Neuropsychopharmacology (2006) 1.55
Dementia induces correlated reductions in white matter integrity and cortical thickness: a multivariate neuroimaging study with sparse canonical correlation analysis. Neuroimage (2010) 1.54
Can MRI screen for CSF biomarkers in neurodegenerative disease? Neurology (2012) 1.52
Cognitive rehabilitation interventions for neglect and related disorders: moving from bench to bedside in stroke patients. J Cogn Neurosci (2006) 1.52
The clinical diagnosis of vascular dementia: A comparison among four classification systems and a proposal for a new paradigm. Clin Neuropsychol (2004) 1.52
Out-of-pocket costs of HAART limit HIV treatment responses in Botswana's private sector. AIDS (2006) 1.51
Deep brain stimulation for movement disorders: morbidity and mortality in 109 patients. J Neurosurg (2003) 1.49
Self-appraisal in behavioural variant frontotemporal degeneration. J Neurol Neurosurg Psychiatry (2012) 1.49
Mild cognitive impairment is common in Parkinson's disease patients with normal Mini-Mental State Examination (MMSE) scores. Parkinsonism Relat Disord (2008) 1.49
Preserved musical semantic memory in semantic dementia. Arch Neurol (2011) 1.48
Reversal of the concreteness effect for verbs in patients with semantic dementia. Neuropsychology (2007) 1.48
Arterial spin labeling blood flow MRI: its role in the early characterization of Alzheimer's disease. J Alzheimers Dis (2010) 1.48
Conceptual representations of action in the lateral temporal cortex. J Cogn Neurosci (2005) 1.47
Clinical, genetic, and pathologic characteristics of patients with frontotemporal dementia and progranulin mutations. Arch Neurol (2007) 1.45
Neuropsychiatric symptoms and medical illness in patients with dementia: an exploratory study. J Am Osteopath Assoc (2006) 1.43
Oops! Resolving social dilemmas in frontotemporal dementia. J Neurol Neurosurg Psychiatry (2006) 1.43
Neural substrates of action event knowledge. J Cogn Neurosci (2002) 1.43
Comparison of cerebrospinal fluid levels of tau and Aβ 1-42 in Alzheimer disease and frontotemporal degeneration using 2 analytical platforms. Arch Neurol (2012) 1.42
Building an integrated neurodegenerative disease database at an academic health center. Alzheimers Dement (2011) 1.41
Distinctions between manipulation and function knowledge of objects: evidence from functional magnetic resonance imaging. Brain Res Cogn Brain Res (2005) 1.41
Neural basis for sentence comprehension: grammatical and short-term memory components. Hum Brain Mapp (2002) 1.40
The core and halo of primary progressive aphasia and semantic dementia. Ann Neurol (2003) 1.39
Localization of sublexical speech perception components. Brain Lang (2010) 1.39
The correlation of cognitive decline with frontotemporal dementia induced annualized gray matter loss using diffeomorphic morphometry. Alzheimer Dis Assoc Disord (2005) 1.39
Risk genotypes at TMEM106B are associated with cognitive impairment in amyotrophic lateral sclerosis. Acta Neuropathol (2010) 1.38
Biomarker discovery for Alzheimer's disease, frontotemporal lobar degeneration, and Parkinson's disease. Acta Neuropathol (2010) 1.38